bisoprolol has been researched along with Lung Diseases, Obstructive in 5 studies
Bisoprolol: A cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.
Lung Diseases, Obstructive: Any disorder marked by obstruction of conducting airways of the lung. AIRWAY OBSTRUCTION may be acute, chronic, intermittent, or persistent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A randomized, placebo-controlled, double-blind crossover investigation in 12 patients with non-asthmatic chronic obstructive lung disease and co-existing stable angina pectoris was done to compare two beta 1-selective adrenoceptor blocking agents, atenolol 100 mg and bisoprolol 20 mg." | 9.06 | Effects of single oral doses of bisoprolol and atenolol on airway function in nonasthmatic chronic obstructive lung disease and angina pectoris. ( Bethge, H; Dorow, P; Tönnesmann, U, 1986) |
| "To compare efficacy and safety of atenolol, methoprolol and bisoprolol, as the most usable beta-blockers, in patients with isolated systolic arterial hypertension (ISAH) and concomitant diabetes mellitus (DM) and/or chronic obstructive pulmonary disease (COPD)." | 5.10 | [Efficacy and safety of different beta-blockers in patients with isolated systolic hypertension associated with diabetes mellitus and obstructive pulmonary diseases]. ( Abakumov, IuE; Batutina, AM; Kukes, VG; Mamaev, VI; Ostroumova, OD; Zykova, AA, 2003) |
| "A randomized, placebo-controlled, double-blind crossover investigation in 12 patients with non-asthmatic chronic obstructive lung disease and co-existing stable angina pectoris was done to compare two beta 1-selective adrenoceptor blocking agents, atenolol 100 mg and bisoprolol 20 mg." | 5.06 | Effects of single oral doses of bisoprolol and atenolol on airway function in nonasthmatic chronic obstructive lung disease and angina pectoris. ( Bethge, H; Dorow, P; Tönnesmann, U, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Remme, WJ | 1 |
| Kukes, VG | 1 |
| Ostroumova, OD | 1 |
| Mamaev, VI | 1 |
| Batutina, AM | 1 |
| Abakumov, IuE | 1 |
| Zykova, AA | 1 |
| Dorow, P | 2 |
| Bethge, H | 1 |
| Tönnesmann, U | 1 |
| Macquin-Mavier, I | 1 |
| Roudot-Thoraval, F | 1 |
| Clerici, C | 1 |
| George, C | 1 |
| Harf, A | 1 |
3 trials available for bisoprolol and Lung Diseases, Obstructive
| Article | Year |
|---|---|
[Efficacy and safety of different beta-blockers in patients with isolated systolic hypertension associated with diabetes mellitus and obstructive pulmonary diseases].
Topics: Adrenergic beta-Antagonists; Atenolol; Bisoprolol; Blood Pressure; Blood Pressure Monitoring, Ambula | 2003 |
Effects of single oral doses of bisoprolol and atenolol on airway function in nonasthmatic chronic obstructive lung disease and angina pectoris.
Topics: Adrenergic beta-Antagonists; Adult; Airway Resistance; Angina Pectoris; Atenolol; Bisoprolol; Double | 1986 |
Comparative effects of bisoprolol and acebutolol in smokers with airway obstruction.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Bisoprolol; Blood Pressure; Female; Heart Rate; Huma | 1988 |
2 other studies available for bisoprolol and Lung Diseases, Obstructive
| Article | Year |
|---|---|
Which beta-blocker is most effective in heart failure?
Topics: Adrenergic beta-Antagonists; Animals; Benzopyrans; Bisoprolol; Carbazoles; Carvedilol; Clinical Tria | 2010 |
Beta 1/beta 2-splitting of bisoprolol.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Airway Resistance; Bisoprolol; Blood Pressure; Coronary Di | 1986 |